-
SICEM 2026
SICEM 2026
- Program
- Abstracts
-
Participation
Participation
- Venue
-
News & Gallery
News & Gallery
LOG IN
SIGN UP
KESScientific program
Diabetes/Obesity/Lipid (clinical)
-
Symposium 1
The new era of ultra-long acting cardiometabolic therapies
Day 2, Friday, April 10, 08:30-10:00 / Room 1(West tower B1F)
Chairpersons : TBD
08:30-09:00
Experience in Japan with the introduction of once-weekly insulin therapy
Hirotaka Watada (Juntendo University, Japan)
09:00-09:30
Maridebart Cafraglutide (MariTide) – the first monthly engineered nutrient-stimulated hormone (NUSH)
Chang Hee Jung (University of Ulsan, Korea)
09:30-10:00
Inclisiran and siRNA lipid-lowering therapies – twice-yearly LDL control
Youngwoo Jang (Gachon University, Korea)
-
Symposium 4
Overcoming the limitations of current GLP-1 receptor agonists
Day 2, Friday, April 10, 13:40-15:10 / Room 1(West tower B1F)
Chairpersons : TBD
13:40-14:10
Retatrutide – triple agonism targeting the boundaries of GLP-1RA efficacy
Stephan Jacob (Cardio Metabolic Institute and University of Tübingen, Germany)
14:10-14:40
Ecnoglutide: Using biased GLP-1R signaling to improve efficacy and tolerability
Jang Won Son (The Catholic University of Korea, Korea)
14:40-15:10
CagriSema: A synergistic approach to greater weight loss and metabolic health
Jae Hyun Bae (Seoul National University, Korea)
-
Symposium 9
Genetic, epigenetic, and environmental interactions in metabolic disorders
Day 3, Saturday, April 11, 08:30-10:00 / Room 1(West tower B1F)
Chairpersons : TBD
08:30-09:00
Large-scale multivariate GWAS, polygenic risk, and obesity endotypes
Hong-Hee Won (Sungkyunkwan University, Korea)
09:00-09:30
Epigenetic regulation of insulin sensitivity
Sona Kang (University of California, Berkeley, USA)
09:30-10:00
Exposome, lifestyle, and gene–environment interactions in metabolic disorders
Jae-Seung Yun (The Catholic University of Korea, Korea)
-
Clinical Update 4
Transforming diabetes management with connected devices
Day 3, Saturday, April 11, 14:50-16:20 / Room 1(West tower B1F)
Chairpersons : TBD
14:50-15:20
Fully closed loop in T2D
Charlotte Boughton (University of Cambridge, UK)
15:20-15:50
Connected insulin pens: An evidence-based strategy for reducing missed bolus doses
Sang-Man Jin (Sungkyunkwan University, Korea)
15:50-16:20
Current trends in CGM enabling data-driven insulin management
Jae Hyeon Kim (Sungkyunkwan University, Korea)
-
Symposium 1
The new era of ultra-long acting cardiometabolic therapies Day 2, Friday, April 10, 08:30-10:00 / Room 1(West tower B1F)
Chairpersons : TBD
|
|
08:30-09:00 | Experience in Japan with the introduction of once-weekly insulin therapy Hirotaka Watada (Juntendo University, Japan) |
|
|
09:00-09:30 | Maridebart Cafraglutide (MariTide) – the first monthly engineered nutrient-stimulated hormone (NUSH) Chang Hee Jung (University of Ulsan, Korea) |
| 09:30-10:00 | Inclisiran and siRNA lipid-lowering therapies – twice-yearly LDL control Youngwoo Jang (Gachon University, Korea) |
-
Symposium 4
Overcoming the limitations of current GLP-1 receptor agonists Day 2, Friday, April 10, 13:40-15:10 / Room 1(West tower B1F)
Chairpersons : TBD
|
|
13:40-14:10 | Retatrutide – triple agonism targeting the boundaries of GLP-1RA efficacy Stephan Jacob (Cardio Metabolic Institute and University of Tübingen, Germany) |
|
|
14:10-14:40 | Ecnoglutide: Using biased GLP-1R signaling to improve efficacy and tolerability Jang Won Son (The Catholic University of Korea, Korea) |
|
|
14:40-15:10 | CagriSema: A synergistic approach to greater weight loss and metabolic health Jae Hyun Bae (Seoul National University, Korea) |
-
Symposium 9
Genetic, epigenetic, and environmental interactions in metabolic disorders Day 3, Saturday, April 11, 08:30-10:00 / Room 1(West tower B1F)
Chairpersons : TBD
|
|
08:30-09:00 | Large-scale multivariate GWAS, polygenic risk, and obesity endotypes Hong-Hee Won (Sungkyunkwan University, Korea) |
|
|
09:00-09:30 | Epigenetic regulation of insulin sensitivity Sona Kang (University of California, Berkeley, USA) |
| 09:30-10:00 | Exposome, lifestyle, and gene–environment interactions in metabolic disorders Jae-Seung Yun (The Catholic University of Korea, Korea) |
-
Clinical Update 4
Transforming diabetes management with connected devices Day 3, Saturday, April 11, 14:50-16:20 / Room 1(West tower B1F)
Chairpersons : TBD
|
|
14:50-15:20 | Fully closed loop in T2D Charlotte Boughton (University of Cambridge, UK) |
|
|
15:20-15:50 | Connected insulin pens: An evidence-based strategy for reducing missed bolus doses Sang-Man Jin (Sungkyunkwan University, Korea) |
|
|
15:50-16:20 | Current trends in CGM enabling data-driven insulin management Jae Hyeon Kim (Sungkyunkwan University, Korea) |
- Korean Endocrine Society
-
101-2503, Lotte Castle President, 109, Mapo-daero, Mapo-gu, Seoul 04146, Republic of Korea
T. +82-2-714-2428 | E. endo@endocrinology.or.kr | W. www.endocrinology.or.kr
Business Registration Number: 106-82-31113 | Name of Representative : Eun-Gyoung Hong
- SICEM 2026 Secretariat (INTO-ON)
-
4F, A-Block, Richensia, 341, Baekbeom-ro, Yongsan-gu, Seoul 04315, Republic of Korea
T. +82-2-2285-2582 | E. sicem2026@into-on.com | W. www.into-on.com
- 전체 방문자 수 : 65409 명
- 금일 방문자 수 : 539 명
Copyright ⓒ The Korean Endocrine Society. All rights Reserved